Proton Pump Inhibitor Use Exceeding the U.S. Food and Drug Administration Approved Treatment Duration for Patients With Peptic Ulcer Disease: A Retrospective Cohort Study
Markers of patient complexity and medication use not meeting gastroprotection guidelines are associated with inappropriate PPI persistence among patients with PUD. These data may inform future targeted PPI deprescribing programs.
Authors
- Jonathan G. Yabes (ORCID: https://orcid.org/0000-0002-9406-2362)
- Timothy S. Anderson (ORCID: https://orcid.org/0000-0002-5384-275X)
- Ravy K. Vajravelu (ORCID: https://orcid.org/0000-0002-6557-3307)
- Robert E. Schoen (ORCID: https://orcid.org/0000-0001-7153-2766)
- Jordan Villars
Institutions
- University of Pittsburgh (US)
- VA Pittsburgh Healthcare System (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1002/pds.70152
- Primary Topic
- Gastrointestinal Bleeding Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute on Aging
- National Institute of Diabetes and Digestive and Kidney Diseases